Relative bioavailability of bedaquiline tablets suspended in water: Implications for dosing in children-Reference-Cited by-同舟云学术

Relative bioavailability of bedaquiline tablets suspended in water: Implications for dosing in children

Published:2018-08-10 Issue:10 Volume:84 Page:2384-2392
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Svensson Elin M.¹²^ORCID,du Bois Jeannine³,Kitshoff Rene³,de Jager Veronique R.³,Wiesner Lubbe⁴,Norman Jennifer⁴,Nachman Sharon⁵,Smith Betsy⁶,Diacon Andreas H.³⁷,Hesseling Anneke C.⁸,Garcia-Prats Anthony J.⁸

Affiliation:

1. Department of Pharmaceutical Biosciences; Uppsala University; Uppsala Sweden

2. Department of Pharmacy, Radboud Institute for Health Sciences; Radboud University Medical Center; Nijmegen The Netherlands

3. TASK Applied Science; Cape Town South Africa

4. Division of Clinical Pharmacology, Department of Medicine; University of Cape Town; Cape Town South Africa

5. Department of Pediatrics; State University of New York Stony Brook; New York USA

6. Division of AIDS; National Institute of Allergy and Infectious Diseases, National Institutes of Health; Bethesada USA

7. Division of Medical Physiology, Faculty of Medicine and Health Sciences; Stellenbosch University; South Africa

8. Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences; Stellenbosch University; Cape Town South Africa

Funder

National Institute of Allergy and Infectious Diseases

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.13696/fullpdf

Reference21 articles.

1. Bedaquiline (BQ)-containing regimen at the programmatic level for MDR-TB: preliminary results;Borisov;Eur Respir J,2017

2. A Diarylquinoline drug active on the ATP synthase of mycobacterium tuberculosis;Andries;Science,2005

3. Bedaquiline: a review of human pharmacokinetics and drug-drug interactions;Heeswijk;J Antimicrob Chemother,2014

4. FDA Center for drug evaluation and research. Application number 204384Orig1s000 https://www.accessdata.fda.gov/drugsatfda_docs/nda/2012/204384Orig1s000ClinPharmR.pdf

5. Model-based estimates of the effects of efavirenz on bedaquiline pharmacokinetics and suggested dose adjustments for patients coinfected with HIV and tuberculosis;Svensson;Antimicrob Agents Chemother,2013

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. [Translated article] Implementation of a traceability and safe drug preparation system in a clean room;Farmacia Hospitalaria;2024-06

2. Formulation development, characterization, and evaluation of bedaquiline fumarate – Soluplus ^® – solid dispersion;Pharmaceutical Development and Technology;2024-05-10

3. Solid dispersions of bedaquiline fumarate to improve its pharmaceutical attributes: A comparative study between PEG and PVP;Journal of Drug Delivery Science and Technology;2024-04

4. Implantación de un sistema de trazabilidad y elaboración segura de medicamentos en la sala blanca;Farmacia Hospitalaria;2024-04

5. Bioanalysis of bedaquiline in human plasma by liquid chromatography-tandem mass spectrometry: Application to pharmacokinetic study;Journal of Mass Spectrometry and Advances in the Clinical Lab;2024-01